is mounjaro a glp-1 medicine Who Candidate For Or Treatment Semaglutide vs. Other GLP-1 Receptor
Description
More recently, clinicians have begun exploring their use in patients with Type 1 diabetes, particularly those with obesity, insulin resistance or features of metabolic syndrome
PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight
Dietary supplements are not appropriate for everyone and may interact with other supplements or medications, so talk to your healthcare provider before adding one to your routine
User reports suggest 2-5 pounds over 4-8 weeks, though these results cannot be separated from concurrent dietary and exercise changes
Fermented Foods Foods that have gone through fermentation, like yogurt, kefir, and kimchi, are packed with probiotics
Figure 1 below depicts the incretin effect in a normal patient versus a diabetic patient
